PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. USO
7. APGE
8. ABBV
9. MSFT
10. IBM

Go back to PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

BTIG Reiterates Neutral Rating on Procept BioRobotics Corp (PRCT)

October 29, 2024 5:49 AM EDT

BTIG analyst Ryan Zimmerman reiterated a Neutral rating on Procept BioRobotics Corp (NASDAQ: PRCT).

The analyst comments "We maintain our Neutral on PRCT shares following 3Q24 results. PRCT has been a battleground stock for multiple quarters now and despite our caution into 3Q24 from a host of dynamics (IV fluid availability, commercial and CMS... More